Europe PMCopen access
Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology
Tumor Microenvironment, Personalized Medicine, Cancer Treatment, Synthetic Biology, Immune System Activation, Bacteria-based Immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 266487
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.